Crinetics Pharmaceuticals (CRNX) Other Non Operating Income (2024 - 2026)

Crinetics Pharmaceuticals' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$131000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 35.47% year-over-year to -$131000.0; the TTM figure through Mar 2026 stood at -$508000.0 (changed N/A YoY), while the FY2025 annual figure was -$357000.0, up 31.21% from the prior year.
• Other Non Operating Income was -$131000.0 for Q1 2026 at Crinetics Pharmaceuticals, down from -$125000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of -$37000.0 in Q3 2024 to a low of -$218000.0 in Q4 2024.
• Historically, Other Non Operating Income has averaged -$127166.7 across 3 years, with a median of -$128000.0 in 2025.
• Biggest YoY gain for Other Non Operating Income was 42.66% in 2025; the steepest drop was 32.43% in 2025.
• A 3-year view of Other Non Operating Income shows it stood at -$218000.0 in 2024, then jumped by 42.66% to -$125000.0 in 2025, then fell by 4.8% to -$131000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$131000.0 (Q1 2026), -$125000.0 (Q4 2025), and -$49000.0 (Q3 2025), per Business Quant data.